Navigation Links
Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Efficacy Data Against Lymphoid Cancers at the 53rd Annual Meeting of the American Society of Hematology (ASH)
Date:12/8/2011

ion are as follows: The IL-3Ralpha-Targeted Drug SL-401 Selectively Kills Blastic Plasmacytoid Dendritic Cell Neoplasm CellsAbstract #: 2588Lead Author:  Fanny Angelot-Delettre, PhD, Institut National de la Sante et de la Recherche MedicaleSession: 614. Acute Lymphoblastic Leukemia - Therapy, excluding Transplantation: Poster IIDate/Time: Sunday, December 11, 2011; 6:00 - 8:00pm PTLocation: Hall GH (San Diego Convention Center) Hodgkin's Lymphoma Cell Lines Have Up-Regulated IL-3 Receptor alpha (IL-3Ralpha) Expression and Are Sensitive to SL-401, An IL-3Ralpha-Targeted Drug Abstract #: 3737Lead Author: Catherine Diefenbach, MD, New York University Cancer InstituteSession: 625. Lymphoma - Pre-Clinical - Chemotherapy and Biologic Agents: Poster IIIDate/Time: Monday, December 12, 2011; 6:00 - 8:00pm PTLocation: Hall GH (San Diego Convention Center) A copy of the above referenced abstracts can be viewed online through the ASH website at www.hematology.org.

About SL-401

SL-401 is a novel clinically active oncology compound that targets the interleukin-3 receptor (IL-3R). IL-3R is overexpressed on cancer stem cells (CSCs) and tumor bulk of multiple hematologic cancers. In a Phase I/II trial of patients with advanced acute myeloid leukemia (AML), SL-401 demonstrated single agent efficacy, including complete responses (CRs) and an overall survival benefit, in heavily pretreated patients. In addition, SL-401 was well-tolerated and was not toxic to the bone marrow. Given these promising results, SL-401 is being advanced into later stage trials in this indication. SL-401 is also being clinically tested in Phase I/II studies of patients with high risk myelodysplastic syndrome (MDS) and advanced chronic myeloid leukemia (CML). SL-401 was granted Orphan Drug Designation by the FDA for the treatment of AML.

About Stemline Therapeutics, Inc.Stemline Therapeutics, Inc. is a clinical stage biopharmac
'/>"/>

SOURCE Stemline Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Stemline Therapeutics Licenses Phase I/II Brain Cancer Vaccine - Shows Promise in Clinical Trial Conducted at University of Pittsburgh
2. Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH)
3. Stemline Therapeutics CEO to Present at IBCs New Frontiers in Cancer Drug Development Conference
4. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
5. Cell Therapeutics, Inc. (CTI) Reports Third Quarter Financial Results and Milestones
6. ALS Therapy Development Institute and Aestus Therapeutics, Inc., Expand Collaboration on Development of Novel ALS Therapies
7. Debiopharm and Ascenta Therapeutics, Inc. Announce An Exclusive License Agreement for the Development and Commercialization of the IAP (Inhibitor of Apoptosis Protein) Inhibitor AT-406 (Called Debio 1143 by Debiopharm) for the Treatment of Various T
8. Nile Therapeutics, Inc. Completes $2.5 Million Private Placement
9. Cell Therapeutics, Inc. (CTI) to Present at Bio Europe Spring 2011
10. Summer Street Research Partners Closes Financing for ImmunoCellular Therapeutics, Ltd.
11. Cell Therapeutics, Inc. (CTI) to Present at Life Science Innovation Northwest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Ga. , Aug. 3, 2015  MiMedx Group, ... company utilizing human amniotic tissue and patent-protected processes to ... Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and ... present at the 35 th Annual Canaccord|Genuity Growth ... H. "Pete" Petit, Chairman and CEO, William C. ...
(Date:8/3/2015)... 2015  Merck KGaA, Darmstadt, Germany ... products in the healthcare, life science and performance materials ... their development and launch of promising new fullerene derivatives ... KGaA, Darmstadt, Germany , is pursuing ... Novel derivatives: highly stable, easy to process ...
(Date:8/3/2015)... Medical, Inc. (Nasdaq: AEMD ), the pioneer in ... announced that it will host its First Quarter Fiscal ... 13, 2015 at 4:30 p.m. Eastern Time. ... fiscal 2016 first quarter results.  A recorded version of ... the call at the Investor Relations portion of the ...
(Date:8/3/2015)... Aug. 3, 2015   Intrexon Corporation (NYSE: ... half and second quarter 2015 financial results after the ... The Company will host a conference call at 5:30 ... general business update. The conference call may ... (International), and asking to join the "Intrexon Corporation Call."  ...
Breaking Biology Technology:MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2Intrexon to Announce First Half and Second Quarter 2015 Financial Results and Host Conference Call on August 10th 2
... Transgenic ... Knock-Out Mouse Models --, HOPKINTON, Mass., Oct. 3 Caliper ... Institute,of Environmental Health Services (NIEHS) has awarded the company a contract,valued ... ten years at the,option of NIEHS. Under the terms of the ...
... EL SEGUNDO, Calif., Oct. 3 Companies identified ... them for,competitive advantage, according to the fifth annual ... Corporation (NYSE: CSC ),Supply Chain Management Review ... supply chain professionals in 21 industries,identifies collaboration as ...
... Oct. 3 Crux Biomedical, Inc., a privately held,medical ... first,implant in the United States of the Crux IVC ... embolism (PE), was implanted at the,Atlanta Medical Center by ... United States, approximately 600,000 patients develop a PE and,between ...
Cached Biology Technology:Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million 22007 Global Survey Identifies Characteristics of Supply Chain Leaders 22007 Global Survey Identifies Characteristics of Supply Chain Leaders 32007 Global Survey Identifies Characteristics of Supply Chain Leaders 4Crux Biomedical Announces First Successful U.S. Implant of Its New Retrievable Inferior Vena Cava (IVC) Filter 2
(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. ... of human interface solutions, today announced a ... first fully hardware encapsulated fingerprint sensor and ... technology is literally off the grid, isolating ... matching within the fingerprint sensor to provide ...
(Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
(Date:7/2/2015)... , July 2, 2015 Fingerprint ... FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor World Peace ... of FPC,s distributors in Asia . Deliveries ... The sensors will be used by smartphone manufacturers in ... is included in the communicated revenue guidance of approximately 2,200 ...
Breaking Biology News(10 mins):Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
... Secure Services Corp.,(SSC), a leader in developing unique ... milestone within the United States. SSC has,successfully integrated ... Constructive Key Management (CKM) cards with Intercede,s,MyID smart ... one of,the first companies in the US to ...
... involved in myelination, the process of protecting a nerves ... breakdown of the nervous systems electrical transmissions in such ... cancers of the nervous system. With $697,065 in ... Injury and the New Jersey Commission on Brain Injury ...
... has a chance to take root and spread, scientists are ... Leading experts from around the globe are gathering to share ... with the hope this work will significantly reduce cancer incidence ... on: , identifying promising targets for drug development; ...
Cached Biology News:Secure Services Corp. Achieves Milestone in United States Identity Protection with the Launch of the SSC SHAPE Card Management Solution 2Secure Services Corp. Achieves Milestone in United States Identity Protection with the Launch of the SSC SHAPE Card Management Solution 3Secure Services Corp. Achieves Milestone in United States Identity Protection with the Launch of the SSC SHAPE Card Management Solution 4Rutgers scientist's research reveals critical knowledge about the nervous system 2
Ezrin/Radixin/Moesin Antibody...
Rabbit Anti-conjugated Agmatine Polyclonal Antibody...
ABCA1 Immunogen: Mouse ABCA1-expressing HeLa stable transfectants. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... ( Abpromise for all tested ... Synthetic peptide based on the propeptide ... amino acid sequence is proprietary) ... SWISS Protein ID: ...
Biology Products: